Julie Smith
CIK: 0001557928
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (15 total)
- Jun 3, 2026STOK
Stoke Therapeutics, Inc.
Award(A)DirectDirector Stock Option (Right to Buy)
17.8K shares- - May 27, 2026EXEL
EXELIXIS, INC.
Award(A)Direct8.4K shares- - Feb 18, 2026EXEL
EXELIXIS, INC.
Exercise(M)Direct44.1K shares at avg. $19.39$855K - Feb 18, 2026EXEL
EXELIXIS, INC.
Sale(S)Direct20K shares at avg. $44.30$887K - Feb 18, 2026EXEL
EXELIXIS, INC.
Exercise(M)Direct20K shares at avg. $21.69$434K - Feb 18, 2026EXEL
EXELIXIS, INC.
Sale(S)Direct44.1K shares at avg. $44.50$2.0M - Feb 17, 2026EXEL
EXELIXIS, INC.
Sale(S)Direct42.4K shares at avg. $43.33$1.8M - Feb 17, 2026EXEL
EXELIXIS, INC.
Exercise(M)Direct42.4K shares at avg. $18.19$772K - Jun 3, 2025STOK
Stoke Therapeutics, Inc.
Award(A)DirectDirector Stock Option (Right to Buy)
29.7K shares- - May 29, 2025EXEL
EXELIXIS, INC.
Award(A)Direct9.8K shares- - Feb 28, 2025EXEL
EXELIXIS, INC.
Exercise(M)Direct19.3K shares at avg. $19.77$381K - Feb 28, 2025EXEL
EXELIXIS, INC.
Sale(S)Direct19.3K shares at avg. $37.62$726K - Feb 27, 2025EXEL
EXELIXIS, INC.
Sale(S)Direct54.5K shares at avg. $38.13$2.1M - Feb 27, 2025EXEL
EXELIXIS, INC.
Exercise(M)Direct31.2K shares at avg. $20.50$639K - Feb 27, 2025EXEL
EXELIXIS, INC.
Exercise(M)Direct23.3K shares at avg. $19.77$462K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 3, 2026 |  STOK Stoke Therapeutics, Inc. | Award(A) Director Stock Option (Right to Buy) | 17,786 | - | - | Direct |
| May 27, 2026 |  EXEL EXELIXIS, INC. | Award(A) | 8,367 | - | $0 | Direct |
| Feb 18, 2026 | EXEL EXELIXIS, INC. | Exercise(M) | 44,087 | $19.39 | $854,847 | Direct |
| Feb 18, 2026 | EXEL EXELIXIS, INC. | Sale(S) | 20,030 | $44.30 | $887,329 | Direct |
| Feb 18, 2026 | EXEL EXELIXIS, INC. | Exercise(M) | 20,030 | $21.69 | $434,451 | Direct |
| Feb 18, 2026 | EXEL EXELIXIS, INC. | Sale(S) | 44,087 | $44.50 | $1,961,872 | Direct |
| Feb 17, 2026 | EXEL EXELIXIS, INC. | Sale(S) | 42,422 | $43.33 | $1,838,145 | Direct |
| Feb 17, 2026 | EXEL EXELIXIS, INC. | Exercise(M) | 42,422 | $18.19 | $771,656 | Direct |
| Jun 3, 2025 | STOK Stoke Therapeutics, Inc. | Award(A) Director Stock Option (Right to Buy) | 29,747 | - | - | Direct |
| May 29, 2025 | EXEL EXELIXIS, INC. | Award(A) | 9,812 | - | - | Direct |
| Feb 28, 2025 | EXEL EXELIXIS, INC. | Exercise(M) | 19,294 | $19.77 | $381,442 | Direct |
| Feb 28, 2025 | EXEL EXELIXIS, INC. | Sale(S) | 19,294 | $37.62 | $725,840 | Direct |
| Feb 27, 2025 | EXEL EXELIXIS, INC. | Sale(S) | 54,514 | $38.13 | $2,078,619 | Direct |
| Feb 27, 2025 | EXEL EXELIXIS, INC. | Exercise(M) | 31,167 | $20.50 | $638,924 | Direct |
| Feb 27, 2025 | EXEL EXELIXIS, INC. | Exercise(M) | 23,347 | $19.77 | $461,570 | Direct |
1-15 of 15 transactions
About Smith Julie
Smith Julie (SEC CIK 0001557928) files insider reports with the SEC as Director of Stoke Therapeutics, Inc. (STOK) and Director of EXELIXIS, INC. (EXEL).
Signal8 holds 6 ownership filings by Smith Julie, all Form 4s, filed between Feb 28, 2025 and Jun 5, 2026. Those filings report 15 transactions, from Feb 27, 2025 to Jun 3, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Smith Julie's filings is in BEDFORD, MA.
Recent filings by Smith Julie
- Jun 3, 2026: Grant or award of STOK derivative securities (Form 4, code A).
- May 27, 2026: Grant or award of EXEL shares (Form 4, code A).
- Feb 18, 2026: Option exercise of EXEL shares (Form 4, code M).
- Feb 18, 2026: Open-market sale of EXEL shares (Form 4, code S).
- Feb 18, 2026: Option exercise of EXEL shares (Form 4, code M).
Other insiders filing for Stoke Therapeutics, Inc. (STOK)
- Allan Jonathan, GENERAL COUNSEL & CORP SEC
- Ticho Barry, CHIEF MEDICAL OFFICER
- Cumbo Alexander, Director
- Kaye Edward M. MD, Director
- Harrison Seth Loring, Director
- McCauley Thomas, Chief Scientific Officer